WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004096209) THE USE OF AZETIDINECARBOXAMIDE DERIVATIVES IN THERAPY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/096209    International Application No.:    PCT/GB2004/001812
Publication Date: 11.11.2004 International Filing Date: 29.04.2004
IPC:
A61K 31/397 (2006.01)
Applicants: VERNALIS RESEARCH LIMITED [GB/GB]; Oakdene Court, 613 Reading Road, Winnersh RG41 5UA (GB) (For All Designated States Except US).
DAVIDSON, James, Edward, Paul [GB/GB]; (GB) (For US Only).
ADAMS, David, Reginald [GB/GB]; (GB) (For US Only).
BICKERDIKE, Michael, John [GB/GB]; (GB) (For US Only).
FLETCHER, Allan [GB/GB]; (GB) (For US Only)
Inventors: DAVIDSON, James, Edward, Paul; (GB).
ADAMS, David, Reginald; (GB).
BICKERDIKE, Michael, John; (GB).
FLETCHER, Allan; (GB)
Agent: WALLS, Alan, James; Vernalis Research Limited, Oakdene Court, 613 Reading Road, Winnersh RG41 5UA (GB)
Priority Data:
0310057.5 01.05.2003 GB
Title (EN) THE USE OF AZETIDINECARBOXAMIDE DERIVATIVES IN THERAPY
(FR) UTILISATION DE DERIVES D'AZETIDINECARBOXAMIDE A DES FINS THERAPEUTIQUES
Abstract: front page image
(EN)The use of a compound of formula (I): wherein: R1 is aryl; R2 is H, alkyl or aryl; and R3 is hydrogen or alkyl; or a pharmaceutically acceptable salt or prodrug thereof, in the manufacture of a medicament for the treatment of a disorder mediated by CB1 receptors.
(FR)L'invention porte sur l'utilisation d'un composé correspondant à la formule (I) dans laquelle R1 est aryle, R2 est H, alkyle ou aryle; et R3 est hydrogène ou alkyle; ou un sel pharmaceutiquement acceptable ou un promédicament de celui-ci, dans la fabrication d'un médicament destiné au traitement d'un trouble à médiation par des récepteurs de CB1.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)